Gyeonggi-do, South Korea

Kiyean Nam

This inventor holds 12 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in CDK Inhibitors. Top assignees: Qurient Co., Ltd., Qurient Co., Ltd., Lead Discovery Center Gmbh. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyean Nam. Retrieved from https://idiyas.com/inventor/kiyean-nam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Seoul, KR (2015)
  • Gyeonggi-do, KR (2021 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
CDK7
Pharmaceutical Composition
Quinoline Derivatives
Anti-Inflammatory
Oral Dosage Form
Pyrazolo-Triazines
5-Lipoxygenase
Prostaglandin E Synthase
TAM RTK
Inhibitory Function
Substituted Pyrazoles
AXL/MER RTK
12 patents (USPTO):Explore Patents

Title: Kiyean Nam: Innovator in Pharmaceutical Compounds

Introduction

Kiyean Nam is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work primarily focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Kiyean Nam has developed different forms of the compound 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide. This invention relates to various forms of the compound, methods of making these forms, and mono-acid addition salts thereof. Additionally, he has patented quinoline derivatives that serve as inhibitors for Axl/Mer RTK and CSF1R. These compounds are particularly relevant for treating hyperproliferative disorders, including various types of cancer and inflammatory diseases.

Career Highlights

Kiyean Nam has worked with notable companies in the pharmaceutical sector, including Qurient Co., Ltd. and Lead Discovery Center GmbH. His experience in these organizations has allowed him to advance his research and development efforts significantly.

Collaborations

Kiyean has collaborated with several professionals in his field, including Jaeseung Kim and Yeejin Jeon. These collaborations have contributed to the success of his innovative projects and patents.

Conclusion

Kiyean Nam is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact various medical fields. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…